Form 4: NHI CIO Kevin Pascoe Granted Restricted Stock

National Health Investors' Chief Investment Officer, Kevin Pascoe, was granted 5,072 shares of restricted common stock.

Summary

• Kevin Carlton Pascoe, Chief Investment Officer of National Health Investors Inc. (NHI), reported an acquisition of common stock.
• The transaction occurred on March 3, 2026.
• Mr. Pascoe acquired 5,072 shares of common stock through a restricted stock grant.
• The grant vests in three equal annual installments, beginning March 3, 2027, contingent on his continued service.
• Following this transaction, Mr. Pascoe beneficially owns 73,428 shares of NHI common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it strengthens the alignment of a key executive's interests with shareholders and supports executive retention, which is generally beneficial for long-term stability.

Positives

• The restricted stock grant aligns the Chief Investment Officer's interests with those of shareholders, incentivizing long-term performance.
• The vesting schedule promotes executive retention, ensuring continuity in leadership.

Negatives

• The issuance of new shares, even restricted, can result in minor dilution for existing shareholders.

Risks

• The restricted stock is subject to forfeiture if the reporting person's service terminates before the vesting dates.

Future Outlook

The restricted stock grant's vesting schedule, commencing March 3, 2027, implies an expectation of continued service from the Chief Investment Officer, aligning his future performance with the company's long-term success.

Industry Context

StockSavvy.ai notes that restricted stock grants are a common form of executive compensation in the REIT sector, designed to align management incentives with long-term shareholder value creation and promote executive retention.

Comparison to Industry Standards

• Executive compensation structures, including restricted stock grants, are standard practice across the real estate investment trust (REIT) industry.
• Companies like Ventas (VTR) and Welltower (WELL) frequently utilize similar equity-based incentives to retain key executives and link their performance to the company's stock performance.
• The size of the grant for a Chief Investment Officer at NHI appears to be within typical ranges for a company of its market capitalization, though specific comparisons would require detailed compensation peer group analysis.

Stakeholder Impact

• Shareholders: Minor potential dilution from the issuance of new shares, but improved alignment of executive interests with long-term shareholder value.
• Employees: The grant structure incentivizes executive retention, potentially contributing to leadership stability.

Next Steps

• The restricted stock will vest in three equal annual installments, with the first installment on March 3, 2027, subject to continued service.

Key Dates

Keywords

National Health Investors, NHI, Kevin Pascoe, Chief Investment Officer, Restricted Stock Grant, Insider Transaction, Executive Compensation, Form 4, Equity Incentive